Astrazeneca Plc

AstraZeneca buying drug developer Alexion for $39 billion

Associated Press

US OKs 1st drug aimed at women with inherited breast cancer

By LINDA A. JOHNSON - Associated Press

FDA OKs immune-boosting drug for advanced bladder cancer

By LINDA A. JOHNSON - Associated Press

Pfizer net plunges 38 pct., misses Street 3Q forecasts

By LINDA A. JOHNSON - Associated Press

New drugs may make a dent in lung, ovarian cancer

By MARILYNN MARCHIONE - Associated Press

Nonprescription Nexium heartburn medicine launches

By LINDA A. JOHNSON - Associated Press

AstraZeneca rejects $119 billion offer from Pfizer

By GREGORY KATZ and LINDA A. JOHNSON - Associated Press

Pfizer CEO responds to governors on AstraZeneca

Associated Press

Md. lawmakers worried about AstraZeneca jobs

Associated Press

2 governors express concerns to Pfizer

Associated Press

AstraZeneca fends off Pfizer with new growth plan

By SYLVIA HUI - Associated Press

AstraZeneca rejects sweetened Pfizer takeover bid

By DANICA KIRKA and LINDA A. JOHNSON - Associated Press

Pfizer still pursuing AstraZeneca after 2nd rebuff

By DANICA KIRKA and LINDA A. JOHNSON - Associated Press

Bristol-Myers completes diabetes business sale

By NEW YORK - Associated Press

European drugmakers hit with poor test results

By GREG KELLER - Associated Press

Questions loom over drug given to sleepless vets

By MATTHEW PERRONE - Associated Press

Watch

Court Watch 'Climate Lawfare' forum: Supreme Court to weigh Suncor v. Boulder dispute

LISTEN: The bureaucracy of war and disease Michael Pack joins Bold and Blunt

LISTEN: Here’s how F-35 ejection seats are made Matt Johnson joins Threat Status

WATCH: Western tolerance and ‘suicidal empathy’ Jed Babbin joins Kelly Sadler

Latest Stories

AstraZeneca buying drug developer Alexion for $39 billion

US OKs 1st drug aimed at women with inherited breast cancer

FDA OKs immune-boosting drug for advanced bladder cancer

Pfizer net plunges 38 pct., misses Street 3Q forecasts

New drugs may make a dent in lung, ovarian cancer

Nonprescription Nexium heartburn medicine launches

AstraZeneca rejects $119 billion offer from Pfizer

Pfizer CEO responds to governors on AstraZeneca

Md. lawmakers worried about AstraZeneca jobs

2 governors express concerns to Pfizer

AstraZeneca fends off Pfizer with new growth plan

AstraZeneca rejects sweetened Pfizer takeover bid

Pfizer still pursuing AstraZeneca after 2nd rebuff

Bristol-Myers completes diabetes business sale

European drugmakers hit with poor test results

Questions loom over drug given to sleepless vets